Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBP
Cohen Yuval sold 17,000 Corbus Pharmaceuticals Holdings, Inc. shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 10, 2026
On Aug 7, 2026, Cohen Yuval (Director, Chief Executive Officer) sold 17,000 Corbus Pharmaceuticals Holdings, Inc. shares at US$10.08 for US$171K under a trading plan, leaving 157,316 shares. Filed Aug 10, 2026 (Form 4).
- Sold
- 17,000 shares
- Price
- US$10.08
- Value
- US$171K
- Holding after
- 157,316 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock, par value $0.0001 per share | Sale | 17,000 | US$10.08 | 157,316 | Direct |
Source
Related
- Corbus Pharmaceuticals Holdings, Inc.
- Cohen Yuval
- Corbus Pharmaceuticals Holdings, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Sep 30, 2026
- Form 4 · Ben Yong · Sep 15, 2026
- Form 4 · Nicacio Leonardo Viana · Aug 17, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Form 4 · Saxena Nishant C · Aug 12, 2026